Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Protocol of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies

NCT00996060 is registered in ClinicalTrials.gov with New Mexico Cancer Research Alliance as lead sponsor.

NCT NCT00996060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00996060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Protocol of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies
Lead sponsor
New Mexico Cancer Research Alliance
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2008
Completion date
January 31, 2013
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer